Pentostatin (2′-deoxycof ormycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: Phase II study of the EORTC early clinical trials group

S. Monfardini, R. Sorio, F. Cavalli, T. H. Cerny, M. Van Glabbeke, S. Kaye, J. F. Smyth

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pentostatin (2′-deoxycof ormycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: Phase II study of the EORTC early clinical trials group'. Together they form a unique fingerprint.

Medicine & Life Sciences